Antibody association with a novel model for primary progressive multiple sclerosis: Induction of relapsing-remitting and progressive forms of EAE in H2(s) mouse strains

Brain Pathology

Volumn 10, Issue 3, 2000, Pages 402-418

  Tsunoda, Ikuo ^a   Kuang, Li Qing ^a   Theil, Diethilde J ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BACTERIAL DNA; MYELIN PROTEIN;

ADOLESCENT; ALLERGIC ENCEPHALOMYELITIS; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; DEMYELINATION; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; SURVIVAL;

EID: 0033920319     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2000.tb00272.x     Document Type: Article

References (74)

1. Abbas AK, Murphy KM, Sher A (1996) Functional diversity of helper T lymphocytes. Nature 383: 787-793
2. Acarín N, Río J, Fernández AL, Tintoré M, Durán I, Galán I, Montalban X (1996) Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis. Acta Neurol Scand 93: 99-103
3. Amor S, Groome N, Linington C, Morris MM, Dornmair K, Gardinier MV, Matthieu J-M, Baker D (1994) Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol 153: 4349-4356
4. Bauer J, Bradl M, Hickey WF, Forss-Petter S, Breitschopf H, Linington C, Wekerle H, Lassmann H (1998) T-cell apoptosis in inflammatory brain lesions: Destruction of T cells does not depend on antigen recognition. Am J Pathol 153: 715-724
5. Booss J, Esiri MM, Tourtellotte WW, Mason DY (1983) Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J Neurol Sci 62: 219-232
6. Bornstein MB, Miller A, Slagle S, Weitzman M, Drexler E, Keilson M, Spada V, Weiss W, Appel S, Rolak L, et al (1991) A placebo-controlled, double-blind, randomized, two-center, pilot trial of Cop 1 in chronic progressive multiple sclerosis. Neurology 41: 533-539
7. Bramanti P, Sessa E, Rifici C, D'Aleo G, Floridia D, Di Bella P, Lublin F (1998) Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b. Neurology 51: 1720-1723
8. Brown AM, McFarlin DE (1981) Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest 45: 278-284
9. Coffman RL, Seymour BW, Lebman DA, Hiraki DD, Christiansen JA, Shrader B, Cherwinski HM, Savelkoul HFJ, Finkelman FD, Bond MW, Mosmann TR (1988) The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol Rev 102: 5-28
10. Cottrell DA, Kremenchutzky M, Rice GPA, Koopman WJ, Hader W, Baskerville J, Ebers GC (1999) The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain 122: 625-639
11. Endoh M, Tabira T, Kunishita T, Sakai K, Yamamura T, Taketomi T (1986) DM-20, a proteolipid apoprotein, is an encephalitogen of acute and relapsing autoimmune encephalomyelitis in mice. J Immunol 137: 3832-3835
12. European Study Group on Interferon β-1b in Secondary Progressive MS (1998) Placebo-controlled multicentre randomised trial of interferon β-1b in treatment of secondary progressive multiple sclerosis. Lancet 352: 1491-1497
13. Fukazawa T, Hamada T, Kikuchi S, Sasaki H, Tashiro K, Maguchi S (1996) Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan. J Neurol Neurosurg Psychiatry 61: 203-204
14. Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K, Okabe S, Koseki H, Hirosawa S, Taniguchi M, Miyasaka N, Tokuhisa T (1997) Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 186: 439-448
15. Gardinier MV, Amiguet P, Linington C, Matthieu J-M (1992) Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily. J Neurosci Res 33: 177-187
16. Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL (1996) Late complications of immune deviation therapy in a nonhuman primate. Science 274: 2054-2057
17. Genain CP, Cannella B, Hauser SL, Raine CS (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat Med 5: 170-175
18. Gold R, Hartung H-P, Lassmann H (1997) T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci 20: 399-404
19. Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK (1996) Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 156: 371-379
20. Guarnieri B, Lolli F, Amaducci L (1985) Polymorphonuclear neutral protease activity in multiple sclerosis and other diseases. Ann Neurol 18: 620-622
21. Hjelmström P, Juedes AE, Fjell J, Ruddle NH (1998) B cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol 161: 4480-4483
22. Johansson U, Sander B, Hultman P (1997) Effects of the murine genotype on T cell activation and cytokine production in murine mercury-induced autoimmunity. J Autoimmun 10: 347-355
23. Johnson MD, Lavin P, Whetsell WO Jr (1990) Fulminant monophasic multiple sclerosis, Marburg's type. J Neurol Neurosurg Psychiatry 53: 918-921
24. Kerlero de Rosbo N, Mendel I, Ben-Nun A (1995) Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes. Eur J Immunol 25: 985-993
25. Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, Reske K, Wekerle H, Linington C (1994) Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100β molecule, a calcium binding protein of astroglia. J Exp Med 180: 817-829
26. Korczyn AD, Nisipeanu P (1996) Safety profile of copolymer 1: analysis of cumulative experience in the United States and Israel. J Neurol 243 [Suppl 1]: S23-S26
27. Larsen JR Kvaale G, Riise T, Nyland H, Aarli JA (1985) Multiple sclerosis - more than one disease? Acta Neurol Scand 72: 145-150
28. Lassmann H, Brunner C, Bradl M, Linington C (1988) Experimental allergic encephalomyelitis: the balance between encephalitogenic T lymphocytes and demyelinating antibodies determines size and structure of demyelinated lesions. Acta Neuropathol (Berl) 75: 566-576
29. Levine S (1974) Hyperacute, neutrophilic, and localized forms of experimental allergic encephalomyelitis: A review. Acta Neuropathol (Berl) 28: 179-189
30. Levine S, Sowinski R (1972) The role of mononuclear cell deficiency in the production of neutrophilic allergic encephalomyelitis: Parabiosis experiments. Proc Soc Exp Biol Med 141: 664-668
31. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu H-C, Lassmann H, Wekerle H (1993) T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23: 1364-1372
32. Linington C, Morgan BP, Scolding NJ, Wilkins P, Piddlesden S, Compston DAS (1989) The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain 112: 895-911
33. Linnington C, Webb M, Woodhams PL (1984) A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol 6: 387-396
34. Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: Results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46: 907-911
35. Mason DY, Cordell J, Brown M, Pallesen G, Ralfkiaer E, Rothbard J, Crumpton M, Gatter KC (1989) Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. J Clin Pathol 42: 1194-1200
36. Matsumoto Y, Kohyama K, Aikawa Y, Shin T, Kawazoe Y, Suzuki Y, Tanuma N (1998) Role of natural killer cells and TCR-γδ T cells in acute autoimmune encephalomyelitis. Eur J Immunol 28: 1681-1688
37. Matthews B (1998) Symptoms and signs of multiple sclerosis. In: McAlpine's Multiple Sclerosis. Compston A, Ebers G, Lassmann H, McDonald I, Matthews B, Wekerle H (eds.), pp. 145-190, Churchill Livingstone, London.
38. Määttä JA, Sjöholm UR, Nygårdas PT, Salmi AA, Hinkkanen AE (1998) Neutrophils secreting tumor necrosis factor alpha infiltrate the central nervous system of BALB/c mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 90: 162-175
39. McColl SR, Staykova MA, Wozniak A, Fordham S, Bruce J, Willenborg DO (1998) Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J Immunol 161: 6421-6426
40. McDonald WI (1994) Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis. J Neuropathol Exp Neurol 53: 338-343
41. Minderhoud JM, van der Hoeven JH, Prange AJ (1988) Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand 78: 10-15
42. Nakashima I, Fujihara K, Endo M, Seki H, Okita N, Takase S, Itoyama Y (1998) Clinical and laboratory features of myelitis patients with anti-neutrophil cytoplasmic antibodies. J Neurol Sci 157: 60-66
43. O'Garra A (1998) Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8: 275-283
44. O'Neill JK, Baker D, Morris MM, Gschmeissner SE, Jenkins HG, Butt AM, Kirvell SL, Amor S (1998) Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: Demyelination and fast axonal transport changes in disease. J Neuroimmunol 82: 210-218
45. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DPE, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 60: 382-387
46. Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Möller E, Carlsson B, Wallin J (1989) Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 86: 7113-7117
47. Pham-Dinh D, Mattei M-G, Nussbaum J-L, Roussel G, Pontarotti P, Roeckel N, Matner IH, Artzt K, Lindahl KF, Dautigny A (1993) Myelin/oligodendrocyte glycoprotein is a member of a subset of the immunoglobulin superfamily encoded within the major histocompatibility complex. Proc Natl Acad Sci USA 90: 7990-7994
48. Piddlesden SJ, Storch MK, Hibbs M, Freeman AM, Lassmann H, Morgan BP (1994) Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J Immunol 152: 5477-5484
49. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI (1994) A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 117: 759-765
50. Ryan MS, Griffin F, Mahon B, Mills KHG (1997) The role of the S-1 and B-oligomer components of pertussis toxin in its adjuvant properties for Th1 and Th2 cells. Biochem Soc Trans 25: 126S
51. Simpson JF, Tourtellotte WW, Kokmen E, Parker JA, Itabashi HH, Mich AA (1969) Fluorescent protein tracing in multiple sclerosis brain tissue. Arch Neurol 20: 373-377
52. Stefferl A, Brehm U, Storch M, Lambracht-Washington D, Bourquin C, Wonigeit K, Lassmann H, Linington C (1999) Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: Disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J Immunol 163: 40-49
53. Stone SH, Lerner EM II (1965) Chronic disseminated allergic encephalomyelitis in guinea pigs. Ann N Y Acad Sci 122: 227-241
54. Storch MK, Stefferl A, Brehm U, Weissert R, Wallström E, Kerschensteiner M, Olsson T, Linington C, Lassmann H (1998) Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol 8: 681-694
55. Suen WE, Bergman CM, Hjelmström P, Ruddle NH (1997) A critical role for lymphotoxin in experimental allergic encephalomyelitis. J Exp Med 186: 1233-1240
56. Sun J, Link H, Olsson T, Xiao B-G, Andersson G, Ekre H-P, Linington C, Diener P (1991) T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 146: 1490-1495
57. Tanuma N, Matsumoto Y (1997) Recent advances in the immune-pathology of experimental autoimmune encephalomyelitis: With special reference to cytokine production in the central nervous system. Neuropathology 17: 152-159
58. Thilenius ARB, Sabelko-Downes KA, Russell JH (1999) The role of the antigen-presenting cell in Fas-mediated direct and bystander killing: Potential in vivo function of Fas in experimental allergic encephalomyelitis. J Immunol 162: 643-650
59. Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi M, Montalban X, De Sá J (1997) Primary progressive multiple sclerosis. Brain 120: 1085-1096
60. Tsunoda I, Fujinami RS (1996) Two models for multiple sclerosis: Experimental allergic encephalomyelitis and Theiler's murine encephalomyelitis virus. J Neuropathol Exp Neurol 55: 673-686
61. Tsunoda I, Kuang L-Q, Tolley ND, Whitton JL, Fujinami RS (1998) Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J Neuropathol Exp Neurol 57: 758-767
62. Tsunoda I, Kurtz CIB, Fujinami RS (1997) Apoptosis in acute and chronic central nervous system disease induced by Theiler's murine encephalomyelitis virus. Virology 228: 388-393
63. Tsunoda I, McCright IJ, Kuang L-Q, Zurbriggen A, Fujinami RS (1997) Hydrocephalus in mice infected with a Theiler's murine encephalomyelitis virus variant. J Neuropathol Exp Neurol 56: 1302-1313
64. Tsunoda I, Tolley ND, Theil DJ, Whitton JL, Kobayashi H, Fujinami RS (1999) Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol 9: 481-493
65. Vicari AP, Zlotnik A (1996) Mouse NK1.1+ T cells: A new family of T cells. Immunol Today 17: 71-76
66. Weissert R, Wallström E, Storch MK, Stefferl A, Lorentzen J, Lassmann H, Linington C, Olsson T (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102: 1265-1273
67. Whitaker JN, Mitchell GW (1997) Clinical features of multiple sclerosis. In: Multiple Sclerosis: Clinical and Pathogenetic Basis. Raine CS, McFarland HF, Tourtellotte WW (eds.), pp. 3-19, Chapman & Hall, London.
68. Willenborg DO, Fordham S, Bernard CCA, Cowden WB, Ramshaw IA (1996) IFN-γ plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 157: 3223-3227
69. Willenborg DO, Fordham SA, Staykova MA, Ramshaw IA, Cowden WB (1999) IFN-γ is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: A possible role for nitric oxide. J Immunol 163: 5278-5286
70. Wilson SB, Kent SC, Patton KT, Orban T, Jackson RA, Exley M, Porcelli S, Schatz DA, Atkinson MA, Balk SP, Strominger JL, Hafler DA (1998) Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes. Nature 391: 177-181
71. Xiao B-G, Linington C, Link H (1991) Antibodies to myelinoligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J Neuroimmunol 31: 91-96
72. Yokoyama M, Zhang J, Whitton JL (1995) DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol 69: 2684-2688
73. + T cells that promptly produce interleukin 4. Proc Natl Acad Sci USA 92: 11931-11934
74. Zhang B-N, Yamamura T, Kondo T, Fujiwara M, Tabira T (1997) Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J Exp Med 186: 1677-1687